Late-onset partial epileptic seizures occurred in 10 patients with symptoms and/or signs of ischemic cerebrovascular disease (ICVD) and were associated with transient ischemic attacks in 7 of them. History, somatic and neurological examinations, laboratory and ancillary investigations and follow-up revealed no other disease which might be...
-
1989 (v1)PublicationUploaded on: April 14, 2023
-
1986 (v1)Publication
Late-onset focal epileptic seizures occurred in 8 patients with ischemic cerebro-vascular disease (ICVD) and were associated with TIAs in 6 of them. History, physical, laboratory, ancillary examinations and follow-up revealed no other disease which might be responsible for the seizures. Moreover, time of onset and appropriate signs of ICVD...
Uploaded on: March 31, 2023 -
1992 (v1)Publication
Although vigabatrin is a promising new antiepileptic drug, its safety has been challenged by the report of dose-dependent central nervous system myelin vacuolation in some preclinical animal studies. Since it has been shown that vacuolation is associated with specific magnetic resonance imaging (MRI) findings in rats and dogs, MRI of the brain...
Uploaded on: March 31, 2023 -
1994 (v1)Publication
No description
Uploaded on: December 5, 2022 -
1993 (v1)Publication
Data on efficacy and safety of vigabatrin over very protracted treatment periods are still limited. This study reports the follow up of 23 responder epileptic patients who continued vigabatrin treatment after completion of the first year, to an overall long-term exposure ranging 21-84 months (median 60; mean 58.0 +/- 24.0 sd). The seizure...
Uploaded on: March 31, 2023 -
1979 (v1)Publication
No description
Uploaded on: March 31, 2023 -
1976 (v1)Publication
No description
Uploaded on: April 14, 2023 -
1989 (v1)Publication
The efficacy and safety of oral vigabatrin (VGB) as add-on therapy in the long-term treatment of poorly controlled epilepsy were evaluated in 19 patients with complex partial seizures, either with or without secondary generalization. The study was run with a single-blind, placebo-controlled, crossover design, and included 2 months of placebo...
Uploaded on: March 31, 2023 -
1994 (v1)Publication
Previous experimental studies have shown that the simultaneous administration of gamma-aminobutyric acid (GABA) and phosphatidylserine (PS) can exert an anticonvulsant activity in different seizure models; moreover, a preliminary trial showed some effect of the association GABA-PS in patients with absence seizures. The aim of this study was to...
Uploaded on: April 14, 2023 -
1987 (v1)Publication
Carbamazepine-induced cardiac conduction disturbance is reported in 2 patients suffering from epilepsy. The cardiac defects disappeared in both patients after carbamazepine was discontinued, and reappeared in 1 patient after treatment was resumed.
Uploaded on: March 31, 2023 -
1993 (v1)Publication
No description
Uploaded on: December 5, 2022 -
1988 (v1)Publication
The antiepileptic activity of the imidazole derivative denzimol has been evaluated in 10 patients with poorly controlled partial epilepsy by adding on the drug to the current therapy, in an open preliminary trial. A sustained drop in seizure frequency greater than 50\% occurred in 5 patients. Although denzimol increased blood concentrations of...
Uploaded on: April 14, 2023 -
1990 (v1)Publication
No description
Uploaded on: April 14, 2023 -
1987 (v1)Publication
The effect of the combined administration of gamma-aminobutyric acid (GABA) and phosphatidylserine was evaluated in a pilot study of 42 patients with drug-resistant epilepsy. The group included patients with complex partial seizures, simple partial seizures and absence seizures. Patients with complex partial seizures and simple partial seizures...
Uploaded on: March 31, 2023 -
1988 (v1)Publication
No description
Uploaded on: April 14, 2023 -
1988 (v1)Publication
No description
Uploaded on: March 31, 2023